1 |
Choi JY, Lyoo CH, Kim JS, Kim KM, Lee M, Ryu YH. Biodistribution and Radiation Dosimetry of [18F] Mefway in Humans. Mol Imaging Biol 2016;18:803-806.
DOI
|
2 |
Choi JY, Lyoo CH, Lee JH, Cho H, Kim KM, Kim JS. Ryu YH. Human Radiation Dosimetry of [(18)F] AV- 1451(T807) to Detect Tau Pathology. Mol Imaging Biol, 2016;18:479-482.
DOI
|
3 |
Bradshaw TJ, Voorbach MJ, Reuter DR, Giamis AM, Mudd SR, Beaver JD. Image quality of Zr-89 PET imaging in the Siemens microPET Focus 220 preclinical scanner. Mol Imaging Biol, 2016;18:377-385.
DOI
|
4 |
Yu AR, Kim HJ, Lim SM, Kim JS. Comparison of Imaging Characteristics of (124)I PET for Determination of Optimal Energy Window on the Siemens Inveon PET. Biomed Res Int, 2016;3067123.
|
5 |
Yu AR, Kim JS. Effect of filters and reconstruction algorithms on I-124 PET in Siemens Inveon PET scanner. J Instrum, 2015;10:P10026-P10026.
DOI
|
6 |
Yu AR, Kim JS, Kang JH, Lim SM. Comparison of reconstruction methods and quantitative accuracy in Siemens Inveon PET scanner. J Instrum, 2015;10:P04001-P04001.
DOI
|
7 |
Lee YS, Kim JS, Kim JY, Kim BI, Lim SM, Kim HJ. Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET/CT. Cancer Biother Radiopharm, 2015;30:27-32.
DOI
|
8 |
Lee YS, Kim JS, Kim KM, Kang JH, Lim SM, Kim HJ. Performance measurement of PSF modeling reconstruction (True X) on Siemens Biograph TruePoint TrueV PET/CT. Ann Nucl Med, 2014;28:340-348.
DOI
|
9 |
Jang SJ, Kim KI, Seo MJ, Kim BS, Kim EJ, Yoon DH, Lee YJ, Lee TS, An GI, Kang JH. Pre-clinical assessment of Cu- 64-NOTA-trastuzumab targeting human epidermal growth factor receptor 2 for convergence radiopharmaceutical. J Nucl Med no. supplement 2 1378 2016;57.
|
10 |
Bao Q, Newport D, Chen M, Stout DB, Chatziioannou AF. Performance evaluation of the inveon dedicated PET preclinical tomograph based on the NEMA NU-4 standards. J Nucl Med, 2009;50:401-408.
DOI
|
11 |
Magota K, Kubo N, Kuge Y, Nishijima K, Zhao S, Tamaki N. Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging, 2011;38:742-752.
DOI
|
12 |
Scodeller P. Hyaluronidase and other extracellular matrix degrading enzymes for cancer therapy: new uses and nanoformulations. J Carcinog Mutagen, 2014;5:1-5.
|
13 |
Wang H, Ducournau C, Saydaminova K, Richter M, Yumul R, Ho M, Carter D, Zubieta C, Fender P, Lieber A. Intracellular Signaling and Desmoglein 2 Shedding Triggered by Human Adenoviruses Ad3, Ad14, and Ad14P1. J Virol, 2015;89:10841-10859.
DOI
|